The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis - Quiz - MDSpire

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

  • By

  • Gavin Giovannoni

  • Louisa James

  • Adekunle A Adeniran

  • Julian Gold

  • Lawrence S Young

  • David L Selwood

  • David Baker

  • Ruth Dobson

  • May 6, 2025

  • 0 min

Share

Original Source(s)

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

  • by Gavin Giovannoni, Louisa James, Adekunle A Adeniran, Julian Gold, Lawrence S Young, David L Selwood, David Baker, Ruth Dobson

  • May 6, 2025

Related Content

Enrichment of Immature CD10low Neutrophils in Individuals Diagnosed with Multiple Sclerosis

Jump assessment on a force plate—an approach to quantify subtle lower limb neuromuscular deficits in people with multiple sclerosis

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort